ADZENYS ER- amphetamine suspension, extended release United States - English - NLM (National Library of Medicine)

adzenys er- amphetamine suspension, extended release

neos therapeutics brands, llc - amphetamine (unii: ck833kgx7e) (amphetamine - unii:ck833kgx7e) - amphetamine 1.25 mg in 1 ml - adzenys er is indicated for the treatment of attention deficit hyperactivity disorder (adhd) in patients 6 years and older [see clinical studies (14)] . adzenys er is contraindicated: - in patients known to be hypersensitive to amphetamine, or other components of adzenys er. hypersensitivity reactions such as angioedema and anaphylactic reactions have been reported in patients treated with other amphetamine products [see adverse reactions (6.2)] . - in patients taking monoamine oxidase inhibitors (maois), or within 14 days of stopping maois (including maois such as linezolid or intravenous methylene blue), because of an increased risk of hypertensive crisis [see warnings and precautions (5.7)  drug interactions (7.1)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to adzenys er d

Paravit-CF capsules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

paravit-cf capsules

parapharm development ltd - phytomenadione; colecalciferol; alpha tocopheryl acetate; retinol palmitate - oral capsule